164 related articles for article (PubMed ID: 37023996)
41. Protective role of free and quercetin-loaded nanoemulsion against damage induced by intracerebral haemorrhage in rats.
Galho AR; Cordeiro MF; Ribeiro SA; Marques MS; Antunes MF; Luz DC; Hädrich G; Muccillo-Baisch AL; Barros DM; Lima JV; Dora CL; Horn AP
Nanotechnology; 2016 Apr; 27(17):175101. PubMed ID: 26965041
[TBL] [Abstract][Full Text] [Related]
42. Quercetin and kaempferol increase the intestinal absorption of isorhamnetin coexisting in Elaeagnus rhamnoides (L.) A. Nelson (Elaeagnaceae) extracts via regulating multidrug resistance-associated protein 2.
Xiao Y; Xin L; Li L; Li G; Shi X; Ji G; Mi J; Xie Y
Phytomedicine; 2019 Feb; 53():154-162. PubMed ID: 30668394
[TBL] [Abstract][Full Text] [Related]
43. Synthetic Pathways and the Therapeutic Potential of Quercetin and Curcumin.
Hasan AA; Tatarskiy V; Kalinina E
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430891
[TBL] [Abstract][Full Text] [Related]
44. Stabilization of quercetin paradoxically reduces its proapoptotic effect on UVB-irradiated human keratinocytes.
Olson ER; Melton T; Dong Z; Bowden GT
Cancer Prev Res (Phila); 2008 Oct; 1(5):362-8. PubMed ID: 19138980
[TBL] [Abstract][Full Text] [Related]
45. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer.
Gao X; Wang B; Wei X; Men K; Zheng F; Zhou Y; Zheng Y; Gou M; Huang M; Guo G; Huang N; Qian Z; Wei Y
Nanoscale; 2012 Nov; 4(22):7021-30. PubMed ID: 23044718
[TBL] [Abstract][Full Text] [Related]
46. Quercetin as an anticancer agent: Focus on esophageal cancer.
Davoodvandi A; Shabani Varkani M; Clark CCT; Jafarnejad S
J Food Biochem; 2020 Sep; 44(9):e13374. PubMed ID: 32686158
[TBL] [Abstract][Full Text] [Related]
47. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling.
Wang K; Liu R; Li J; Mao J; Lei Y; Wu J; Zeng J; Zhang T; Wu H; Chen L; Huang C; Wei Y
Autophagy; 2011 Sep; 7(9):966-78. PubMed ID: 21610320
[TBL] [Abstract][Full Text] [Related]
48. Quercetin Impedes Th17 Cell Differentiation to Mitigate Arthritis Involving PPARγ-Driven Transactivation of SOCS3 and Redistribution Corepressor SMRT from PPARγ to STAT3.
Yang Y; Shi GN; Wu X; Xu M; Chen CJ; Zhou Y; Wei YZ; Wu L; Cui FF; Sun L; Zhang TT
Mol Nutr Food Res; 2022 Jun; 66(12):e2100826. PubMed ID: 35384292
[TBL] [Abstract][Full Text] [Related]
49. The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway.
Gulati N; Laudet B; Zohrabian VM; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2006; 26(2A):1177-81. PubMed ID: 16619521
[TBL] [Abstract][Full Text] [Related]
50. Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy.
Han X; Xu T; Fang Q; Zhang H; Yue L; Hu G; Sun L
Redox Biol; 2021 Aug; 44():102010. PubMed ID: 34082381
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA targeting by quercetin in cancer treatment and chemoprotection.
Kim DH; Khan H; Ullah H; Hassan STS; Šmejkal K; Efferth T; Mahomoodally MF; Xu S; Habtemariam S; Filosa R; Lagoa R; Rengasamy KR
Pharmacol Res; 2019 Sep; 147():104346. PubMed ID: 31295570
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of mTOR signaling by quercetin in cancer treatment and prevention.
Bruning A
Anticancer Agents Med Chem; 2013 Sep; 13(7):1025-31. PubMed ID: 23272907
[TBL] [Abstract][Full Text] [Related]
53. Potential of the Flavonoid Quercetin to Prevent and Treat Cancer - Current Status of Research.
Jana N; Břetislav G; Pavel S; Pavla U
Klin Onkol; 2018; 31(3):184-190. PubMed ID: 30441971
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic charm of quercetin and its derivatives: a review of research and patents.
Sharma A; Kashyap D; Sak K; Tuli HS; Sharma AK
Pharm Pat Anal; 2018 Jan; 7(1):15-32. PubMed ID: 29227203
[TBL] [Abstract][Full Text] [Related]
55. Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer.
Sharma G; Park J; Sharma AR; Jung JS; Kim H; Chakraborty C; Song DK; Lee SS; Nam JS
Pharm Res; 2015 Feb; 32(2):723-35. PubMed ID: 25186442
[TBL] [Abstract][Full Text] [Related]
56. The flavonoid fisetin as an anticancer agent targeting the growth signaling pathways.
Rengarajan T; Yaacob NS
Eur J Pharmacol; 2016 Oct; 789():8-16. PubMed ID: 27377217
[TBL] [Abstract][Full Text] [Related]
57. Design, optimization, characterization and in-vivo evaluation of Quercetin enveloped Soluplus®/P407 micelles in diabetes treatment.
Singh J; Mittal P; Vasant Bonde G; Ajmal G; Mishra B
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S546-S555. PubMed ID: 30322273
[TBL] [Abstract][Full Text] [Related]
58. Quercetin/chitosan-graft-alpha lipoic acid micelles: A versatile antioxidant water dispersion with high stability.
Shen F; Zhong H; Ge W; Ren J; Wang X
Carbohydr Polym; 2020 Apr; 234():115927. PubMed ID: 32070546
[TBL] [Abstract][Full Text] [Related]
59. Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer.
Srinivasan A; Thangavel C; Liu Y; Shoyele S; Den RB; Selvakumar P; Lakshmikuttyamma A
Mol Carcinog; 2016 May; 55(5):743-56. PubMed ID: 25968914
[TBL] [Abstract][Full Text] [Related]
60. Quercetin alleviates Cadmium-induced autophagy inhibition via TFEB-dependent lysosomal restoration in primary proximal tubular cells.
Zhao Y; Li ZF; Zhang D; Wang ZY; Wang L
Ecotoxicol Environ Saf; 2021 Jan; 208():111743. PubMed ID: 33396069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
